Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) have received an average recommendation of “Moderate Buy” from the fourteen analysts that are covering the company, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $22.25.

Several equities research analysts recently weighed in on SBRA shares. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Sabra Healthcare REIT in a report on Wednesday, July 22nd. Truist Financial boosted their price objective on Sabra Healthcare REIT from $22.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, July 22nd. Citigroup reissued a “market outperform” rating on shares of Sabra Healthcare REIT in a research note on Wednesday, July 22nd. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the stock an “overweight” rating in a report on Monday, June 1st. Finally, Barclays initiated coverage on shares of Sabra Healthcare REIT in a research note on Tuesday, July 7th. They issued an “overweight” rating and a $21.00 target price on the stock.

Sabra Healthcare REIT Stock Performance

Sabra Healthcare REIT stock opened at $21.08 on Thursday. The firm has a fifty day simple moving average of $19.78 and a two-hundred day simple moving average of $19.96. The company has a quick ratio of 4.72, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT has a twelve month low of $17.17 and a twelve month high of $22.77. The company has a market capitalization of $5.39 billion, a PE ratio of 81.08, a P/E/G ratio of 1.60 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings data on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The company had revenue of $230.11 million for the quarter, compared to the consensus estimate of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The firm’s quarterly revenue was up 24.7% compared to the same quarter last year. During the same period last year, the business posted $0.38 earnings per share. Research analysts expect that Sabra Healthcare REIT will post 1.51 EPS for the current year.

Sabra Healthcare REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, August 31st. Shareholders of record on Friday, August 14th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 5.7%. The ex-dividend date of this dividend is Friday, August 14th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is 461.54%.

Hedge Funds Weigh In On Sabra Healthcare REIT

A number of hedge funds have recently modified their holdings of SBRA. Dockside LLC bought a new position in shares of Sabra Healthcare REIT during the second quarter valued at about $605,000. Wedge Capital Management L L P NC boosted its holdings in shares of Sabra Healthcare REIT by 12.8% during the second quarter. Wedge Capital Management L L P NC now owns 245,826 shares of the real estate investment trust’s stock worth $4,796,000 after purchasing an additional 27,822 shares during the period. Hennion & Walsh Asset Management Inc. grew its stake in shares of Sabra Healthcare REIT by 18.5% in the second quarter. Hennion & Walsh Asset Management Inc. now owns 121,559 shares of the real estate investment trust’s stock worth $2,372,000 after purchasing an additional 18,954 shares during the last quarter. Versant Capital Management Inc grew its stake in shares of Sabra Healthcare REIT by 70.0% in the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock worth $29,000 after purchasing an additional 603 shares during the last quarter. Finally, Western Wealth Management LLC purchased a new position in Sabra Healthcare REIT during the 1st quarter valued at about $294,000. Hedge funds and other institutional investors own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.